ELISABETH PHARMACON
Rokycanova 4437/5
615 00 BRNO-Zidenice
Czech Republic
Kits: | EliGene® Mycoplasma Pneumoniae UNI Kit (ref: 90055-UNI) |
---|---|
Package size: |
50 reactions |
Analytical specificity: | Mycoplasma pneumoniae |
Specimens: | sputum, bronchoalveolar lavage, nasopharyngeal swab, nasopharyngeal aspirate |
Compatible instruments: |
ABI 7300, ABI 7500 (FAST) (Applied Biosystems); LightCycler® 480, LightCycler® Nano, LightCycler® 2.0 (Roche); RotorGene 6000 or RotorGene Q (Qiagen); MyGo Mini, MyGo Pro (IT-IS Life Science) |
CE certification: | yes |
Detection technology: | Molecular Beacons |
Clinical study description and results: | |
Within the frame of testing the functional characteristics of EliGene® Mycoplasma pneumoniae UNI Kit, totally 50 clinical specimens (swabs) were analyzed. The EliGene® Mycoplasma pneumoniae UNI Kit diagnosed correctly 6 specimens as Mycoplasma pneumoniae positive. Totally 44 specimens were rightly determined by EliGene® Mycoplasma pneumoniae UNI as Mycoplasma pneumoniae negative. Sensitivity: 100 % Specificity: 100 % |
|
Pathogen description: | |
Mycoplasma pneumoniae belonging to class Mollicutes has one of the smallest known genomes. It lacks a peptidoglycan cell wall and thus it is resistant to the effects of penicillins and other beta-lactam antibiotics. In humans it causes atypical pneumonia. M. pneumoniae infects the upper and lower respiratory tracts, leading to upper respiratory tract infection, tracheobronchitis, bronchitis and community-acquired pneumonia. Infections of the lower respiratory tract generally manifest with a cough, sometimes with dyspnoea, adenopathy, wheezing and, rarely, with respiratory failure. Although M. pneumoniae infections are usually mild, and many are asymptomatic, they are not always self-limiting. M. pneumoniae causes up to 40% of cases of community-acquired pneumonia, but M. pneumoniae respiratory tract infections are also associated with a wide range of extra-pulmonary manifestations, including neurological, cardiac, dermatological, musculoskeletal, haematological and gastrointestinal symptoms. | |
References: |
|
Sánchez-Vargas FM, Gómez-Duarte OG. 2008. Mycoplasma pneumoniae-an emerging extra-pulmonary pathogen. Clin Microbiol Infect. 14(2):105-17. |